loading
Bolt Biotherapeutics Inc stock is traded at $5.15, with a volume of 12,571. It is up +5.32% in the last 24 hours and down -13.45% over the past month. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
See More
Previous Close:
$4.89
Open:
$4.73
24h Volume:
12,571
Relative Volume:
0.45
Market Cap:
$9.87M
Revenue:
$7.88M
Net Income/Loss:
$-69.20M
P/E Ratio:
-2.8142
EPS:
-1.83
Net Cash Flow:
$-69.73M
1W Performance:
+0.00%
1M Performance:
-13.45%
6M Performance:
-47.23%
1Y Performance:
-62.69%
1-Day Range:
Value
$4.73
$5.184
1-Week Range:
Value
$4.59
$5.184
52-Week Range:
Value
$4.59
$14.36

Bolt Biotherapeutics Inc Stock (BOLT) Company Profile

Name
Name
Bolt Biotherapeutics Inc
Name
Phone
650-665-9295
Name
Address
900 CHESAPEAKE DRIVE, REDWOOD CITY
Name
Employee
52
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
BOLT's Discussions on Twitter

Compare BOLT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
BOLT
Bolt Biotherapeutics Inc
5.15 9.72M 7.88M -69.20M -69.73M -1.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-06-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-02-21 Initiated Guggenheim Buy
Mar-02-21 Initiated Morgan Stanley Overweight
Mar-02-21 Initiated SVB Leerink Outperform
Mar-02-21 Initiated Stifel Buy

Bolt Biotherapeutics Inc Stock (BOLT) Latest News

pulisher
Aug 20, 2025

Should you hold or exit Bolt Biotherapeutics Inc. nowJuly 2025 Decliners & Smart Money Movement Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Why Bolt Biotherapeutics Inc. stock attracts strong analyst attentionJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Why Bolt Biotherapeutics Inc. is moving todayWeekly Market Outlook & Safe Entry Trade Signal Reports - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is Bolt Biotherapeutics Inc. forming a bottoming base2025 Biggest Moves & Real-Time Volume Triggers - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Long term hold vs stop loss in Bolt Biotherapeutics Inc.Quarterly Portfolio Report & Weekly Watchlist for Hot Stocks - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Key resistance and support levels for Bolt Biotherapeutics Inc.2025 Retail Activity & High Return Stock Watch Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What recovery options are there for Bolt Biotherapeutics Inc.Sell Signal & Low Drawdown Trading Techniques - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Evaluating Bolt Biotherapeutics Inc. with trendline analysisJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Published on: 2025-08-20 20:23:38 - thegnnews.com

Aug 20, 2025
pulisher
Aug 19, 2025

How Bolt Biotherapeutics Inc. stock performs during market volatilityEarnings Growth Summary & Technical Pattern Based Buy Signals - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Multi asset correlation models including Bolt Biotherapeutics Inc.Quarterly Profit Report & Stepwise Entry/Exit Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Bolt Biotherapeutics Reports Reduced Losses and Revenue Growth - TipRanks

Aug 19, 2025
pulisher
Aug 18, 2025

Moving Average Crossover Confirms Uptrend in Bolt Biotherapeutics Inc.July 2025 Technicals & Low Risk Investment Opportunities - beatles.ru

Aug 18, 2025
pulisher
Aug 18, 2025

Heatmap analysis for Bolt Biotherapeutics Inc. and competitorsWeekly Risk Summary & Proven Capital Preservation Tips - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Trend analysis for Bolt Biotherapeutics Inc. this weekPortfolio Growth Summary & High Conviction Buy Zone Picks - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

What MACD signals say about Bolt Biotherapeutics Inc.Bull Run & Weekly High Momentum Picks - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will breakout in Bolt Biotherapeutics Inc. lead to full recoveryMarket Performance Report & Verified Momentum Watchlists - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Best data tools to analyze Bolt Biotherapeutics Inc. stock2025 Major Catalysts & Accurate Technical Buy Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Using economic indicators to assess Bolt Biotherapeutics Inc. potential2025 Top Gainers & Daily Volume Surge Signals - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will Bolt Biotherapeutics Inc. bounce back from current supportWeekly Risk Summary & Weekly Momentum Picks - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Lake Street Capital Forecasts Strong Price Appreciation for Bolt Biotherapeutics (NASDAQ:BOLT) Stock - Defense World

Aug 17, 2025
pulisher
Aug 17, 2025

Bolt Biotherapeutics (NASDAQ:BOLT) Stock Price Expected to Rise, Lake Street Capital Analyst Says - Defense World

Aug 17, 2025
pulisher
Aug 16, 2025

Is Bolt Biotherapeutics Inc. meeting your algorithmic filter criteriaQuarterly Portfolio Report & Verified High Yield Trade Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Short interest data insights for Bolt Biotherapeutics Inc.July 2025 Recap & Expert Curated Trade Ideas - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Can technical indicators confirm Bolt Biotherapeutics Inc.’s reversal2025 Breakouts & Breakdowns & Community Shared Stock Ideas - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Can momentum traders help lift Bolt Biotherapeutics Inc.July 2025 Highlights & Free Verified High Yield Trade Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Cautious Hold Rating on Bolt Biotherapeutics Amid Uncertain Trial Outcomes and Financial Sustainability - TipRanks

Aug 15, 2025
pulisher
Aug 15, 2025

Bolt Biotherapeutics 2025 Q2 Earnings 59.6% Reduction in Net Loss - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Intraday pattern recognizer results for Bolt Biotherapeutics Inc.2025 Buyback Activity & Weekly Stock Breakout Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Bolt Biotherapeutics Inc.: Q2 Earnings Snapshot - Norwalk Hour

Aug 15, 2025
pulisher
Aug 15, 2025

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts

Aug 15, 2025
pulisher
Aug 14, 2025

Bolt Biotherapeutics: A Case Study in Operational Efficiency and Revenue Upside in Early-Stage Biotech - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Bolt Biotherapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Resul - GuruFocus

Aug 14, 2025
pulisher
Aug 14, 2025

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times

Aug 14, 2025
pulisher
Aug 14, 2025

Bolt Bio's New Cancer Drug Enters Clinical Trials as Company Extends Cash Runway Through 2026 - Stock Titan

Aug 14, 2025

Bolt Biotherapeutics Inc Stock (BOLT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Bolt Biotherapeutics Inc Stock (BOLT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Quinn William P.
President, CEO and CFO
Dec 16 '24
Buy
0.50
2,500
1,241
41,272
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):